My favorite social media ninja -- @psufka shares valuable advice for anyone who wants to jump on the #twitter bandwagon. @cappelliMD joins the party! Distilled + bite-sized information = make the Twittersphere a hit! #ACR19 @RheumNow https://t.co/52und6yfwM

Does anti-TNF treatment halt radiographc progression in ankylosing spondylitis? #ACR19 @RheumNow Vote here 👇

We start our conversation w/ #SoMe enthusiast @JonathanDauMD ! Twitter truly is an excellent resource during fellowship. #ACR19 @RheumNow https://t.co/lDAL3ubIKC

#ACR19 Poll: What sequence of meds should be used to treat a new case of *severe* seropositive RA? (assume no insurance issues and no comorbidities) @rheumnow

Do you routinely use TNF inhibitors in your autoimmune patients with preexisting CHF?

Hope to see everyone tomorrow! Abstract #1157 @rheum_cat #ACR19 https://t.co/6zhNv9YZdD

• Rheum Cat on Twitter: "@DrKanikaMonga and I will be presenting poster 1157…

What a pleasant surprise to be included in the #axSpA poster tour today — my research - showing an association with work related disability in patients with occupations requiring greater trunk strength. 🥰 Thank you to everyone that stopped by! #ACR19 abstract#625 @RheumNow https://t.co/X8UtThiJHM

• Rheum Cat on Twitter: "@DrKanikaMonga featured on the #axSpA poster tour w…

Abstr# 155: Educational poster from U of MN fellow @mill3558 looking at effect of musculoskeletal teaching for 1st year interns (compared to PGY-2 who had not received MSK teaching) — showed long term improvement in rheum knowledge and MSK exam skills. #ACR19 @rheumnow https://t.co/UXfB5t22F6

Dr. Zuily, Dr. Barbhaiya, and Dr. Erkan presented today at #ACR19 results of phase 2 of the development of New Classification Criteria for #APS. They also commented that phase 3 is ongoing. https://t.co/B6g4SJ3CzU https://t.co/xTLXFh2Fg6

• Development of New International Classification Criteria for Antiphospholipid S…

Mike Lee tells us the complex differential Dx of fleeting blindness- GCA is but one Dx ⁦@MdWarrington⁩ @hajj@ #ACR19 https://t.co/Px6AApAiQU

Nice to meet you at the Tweet up @LCalabreseDO @CCalabreseDO.. you missed the photo but not the salute with the friends 🙋 @ClevelandClinic 🏥 #ACR19 #Atlanta su amigo de México! https://t.co/5vtwWIDDpo

SSc gut has poor QoL. Study shows more severe symptoms are associated with worse pathology. So believe the pts and treat what you can. High dose PPIs, promotility drugs, antibiotics for SIBO, laxatives for constipation and Rx for diarrhea. #ACR2019 @RheumNow Abst735 https://t.co/xcFrXXazql

Actually 30 days is still a great window for TA bx. By me. https://t.co/6H5NziUA0G

• Mohammad A. Ursani MD, RhMSUS on Twitter: "That’s a tough window to make! …

🌞 " I am not discouraged because every wrong attempt discarded is another step forward.” - Thomas Edison The future is bright! - Dr. Manzi #ACR19 @RheumNow

Woo hoo! @rheum_cat and her poster on CV disease risk in aXSpA abstr #622 #ACR19 https://t.co/eaDyCKZs5J